Halozyme Therapeutics shares owned by Advisor Group Holdings
Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Advisor Group Holdings
from 13F filings
Historical chart of Advisor Group Holdings investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Advisor Group Holdings consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Advisor Group Holdings
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $37k | 43 | 864.37 |
| 2023-09-30 | $36k | 43 | 843.77 |
| 2023-06-30 | $36k | 43 | 830.53 |
| 2023-03-31 | $36k | 43 | 847.49 |
| 2022-12-31 | $42k | 43 | 976.74 |
| 2022-09-30 | $36k | 43 | 837.21 |
| 2022-06-30 | $38k | 43 | 883.72 |